Compare AbCellera Biologics Inc (ABCL) vs Rent the Runway Inc (RENT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Rent the Runway Inc — how do they compare? AbCellera Biologics Inc trades at $9.5 (market cap $2.99B), while Rent the Runway Inc trades at $3.61 (market cap $122.65M). The key difference: AbCellera Biologics Inc is far larger — about 24.4× Rent the Runway Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Rent the Runway Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | RENT | |
|---|---|---|
Market Cap | $2.99B | $122.65M |
Sector | Health | Consumer Cyclical |
52-Week High | $9.76 | $9.39 |
52-Week Low | $2.78 | $3.01 |
Enterprise Value | $2.58B | $282.75M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbCellera Biologics (ABCL) surged 34.78% to $9.34, driven by positive Phase 2 trial results for its menopause drug ABCL635. Despite negative net income margins and cash burn, analyst consensus is strongly bullish with a $15.50 price target. The stock shows a bullish technical trend, with support at $8 and resistance at $10, though RSI levels indicate overbought conditions.
The outlook hinges on ABCL635's clinical progress and future revenue potential, but high valuation ratios and persistent losses pose significant risks. Investor sentiment is optimistic due to recent drug trial success, yet the company must demonstrate a path to profitability to justify current market enthusiasm.
RENT trades at $3.64, down 1.09% on the day, with a bullish technical signal from moving averages. The company reported Q1 2026 revenue growth of 29.2% year-over-year to $89.9 million, beating expectations, but net losses persist. Analyst sentiment is mixed with 42% buy ratings, while cash flow remains negative and debt levels are elevated.
The outlook hinges on execution under new leadership to achieve profitability. Investment opportunity lies in low valuation multiples if subscriber growth accelerates, but risks include high leverage and sustained cash burn. Wall Street consensus leans cautious despite recent earnings beats.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Rent the Runway Inc
Rent the Runway Inc is an e-commerce platform that allows users to rent, subscribe, or buy designer apparel and accessories.
Read more on RENT →
